JP2022548796A5 - - Google Patents
Info
- Publication number
- JP2022548796A5 JP2022548796A5 JP2022518818A JP2022518818A JP2022548796A5 JP 2022548796 A5 JP2022548796 A5 JP 2022548796A5 JP 2022518818 A JP2022518818 A JP 2022518818A JP 2022518818 A JP2022518818 A JP 2022518818A JP 2022548796 A5 JP2022548796 A5 JP 2022548796A5
- Authority
- JP
- Japan
- Prior art keywords
- chimeric polypeptide
- cell
- polypeptide according
- sequence
- domain
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025171960A JP2026047360A (ja) | 2019-09-24 | 2025-10-10 | ヒンジドメインを有するノッチ受容体 |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962905251P | 2019-09-24 | 2019-09-24 | |
| US201962905263P | 2019-09-24 | 2019-09-24 | |
| US62/905,251 | 2019-09-24 | ||
| US62/905,263 | 2019-09-24 | ||
| PCT/US2020/052327 WO2021061862A1 (en) | 2019-09-24 | 2020-09-23 | Notch receptors with hinge domain |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025171960A Division JP2026047360A (ja) | 2019-09-24 | 2025-10-10 | ヒンジドメインを有するノッチ受容体 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022548796A JP2022548796A (ja) | 2022-11-21 |
| JP2022548796A5 true JP2022548796A5 (https=) | 2023-10-03 |
Family
ID=75167117
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022518818A Pending JP2022548796A (ja) | 2019-09-24 | 2020-09-23 | ヒンジドメインを有するノッチ受容体 |
| JP2025171960A Pending JP2026047360A (ja) | 2019-09-24 | 2025-10-10 | ヒンジドメインを有するノッチ受容体 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025171960A Pending JP2026047360A (ja) | 2019-09-24 | 2025-10-10 | ヒンジドメインを有するノッチ受容体 |
Country Status (21)
| Country | Link |
|---|---|
| US (3) | US11202801B2 (https=) |
| EP (2) | EP4034252B1 (https=) |
| JP (2) | JP2022548796A (https=) |
| KR (1) | KR20220087454A (https=) |
| CN (2) | CN114761084B (https=) |
| AU (1) | AU2020355031A1 (https=) |
| BR (1) | BR112022005283A2 (https=) |
| CA (1) | CA3155661A1 (https=) |
| DK (1) | DK4034252T3 (https=) |
| ES (1) | ES3008682T3 (https=) |
| FI (1) | FI4034252T3 (https=) |
| HR (1) | HRP20250135T1 (https=) |
| HU (1) | HUE069963T2 (https=) |
| IL (2) | IL307609B2 (https=) |
| LT (1) | LT4034252T (https=) |
| PL (1) | PL4034252T3 (https=) |
| PT (1) | PT4034252T (https=) |
| RS (1) | RS66476B1 (https=) |
| SI (1) | SI4034252T1 (https=) |
| SM (1) | SMT202500031T1 (https=) |
| WO (1) | WO2021061862A1 (https=) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2020355031A1 (en) | 2019-09-24 | 2022-05-19 | The Regents Of The University Of California | Notch receptors with hinge domain |
| CN115666726A (zh) * | 2020-04-09 | 2023-01-31 | 加利福尼亚大学董事会 | 具有铰链结构域的人源化Notch受体 |
| CN117255799A (zh) * | 2021-03-23 | 2023-12-19 | 加利福尼亚大学董事会 | 用于定制抗原诱导的转录调控的合成膜间蛋白水解受体 |
| JP2024537991A (ja) | 2021-10-14 | 2024-10-18 | アーセナル バイオサイエンシズ インコーポレイテッド | 共発現されるｓｈＲＮＡと論理ゲートシステムとを有する免疫細胞 |
| EP4444748A4 (en) * | 2021-12-07 | 2025-12-24 | Univ California | SYNTHETIC CYTOKINE CIRCUITS TO PROMOTE INFILTRATION AND ELIMINATION OF SOLID TUMORS EXCLUDED FROM THE IMMUNE SYSTEM BY MODIFIED IMMUNE CELLS |
| CN114349840B (zh) * | 2021-12-13 | 2024-07-12 | 中山大学肿瘤防治中心（中山大学附属肿瘤医院、中山大学肿瘤研究所） | 一种融合蛋白及其制备方法与应用 |
| CN114621929B (zh) * | 2021-12-21 | 2023-05-30 | 河南省肿瘤医院 | 一种抗肿瘤树突状细胞及其制备方法、表达载体及应用 |
| AU2023273025A1 (en) * | 2022-05-16 | 2024-11-28 | The Regents Of The University Of California | T cell activation responsive constructs for enhanced car-t cell therapy |
| IL322949A (en) | 2023-03-03 | 2025-10-01 | Arsenal Biosciences Inc | Systems targeting PSMA and CA9 |
| WO2024249416A2 (en) * | 2023-06-01 | 2024-12-05 | Vanderbilt University | Engineered cells to detect and respond to amyloid beta peptides |
| CN117304343B (zh) * | 2023-10-11 | 2024-05-07 | 北京景达生物科技有限公司 | Gpc3靶向的car-nk细胞的制备及其应用 |
| CN120248130A (zh) * | 2023-12-28 | 2025-07-04 | 上海恩凯细胞技术有限公司 | 特异性靶向肿瘤的转基因重组免疫细胞及其应用 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX9700800A (es) * | 1994-08-02 | 1997-11-29 | Gen Hospital Corp | Células portadoras de receptores de señuelo cd4 y moléculas y métodos relacionados. |
| NZ759969A (en) * | 2013-12-20 | 2022-12-23 | Fred Hutchinson Cancer Center | Tagged chimeric effector molecules and receptors thereof |
| KR102624023B1 (ko) * | 2015-02-24 | 2024-01-11 | 더 리젠츠 오브 더 유니버시티 오브 캘리포니아 | 결합-촉발된 전사 스위치 및 이들의 이용 방법 |
| IL260532B2 (en) * | 2016-01-11 | 2023-12-01 | Univ Leland Stanford Junior | Chimeric proteins- containing systems and uses thereof in regulating gene expression |
| CN109843929B (zh) * | 2016-08-23 | 2024-07-05 | 加利福尼亚大学董事会 | 蛋白水解可切割的嵌合多肽及其使用方法 |
| EP3568466A4 (en) * | 2017-01-10 | 2020-07-15 | The General Hospital Corporation | TARGETED T CELLS WITH CYTOTOXICITY TO IMMUNOSUPPRESSIVE CELLS |
| US11325957B2 (en) * | 2017-06-19 | 2022-05-10 | Cell Design Labs, Inc. | Methods and compositions for reducing the immunogenicity of chimeric notch receptors |
| US10724680B2 (en) * | 2017-07-06 | 2020-07-28 | Robert Anthony Benson, SR. | Personal device holder |
| US11771718B2 (en) * | 2017-10-18 | 2023-10-03 | Precigen, Inc. | Polypeptide compositions comprising spacers |
| AU2020355031A1 (en) | 2019-09-24 | 2022-05-19 | The Regents Of The University Of California | Notch receptors with hinge domain |
-
2020
- 2020-09-23 AU AU2020355031A patent/AU2020355031A1/en active Pending
- 2020-09-23 JP JP2022518818A patent/JP2022548796A/ja active Pending
- 2020-09-23 HR HRP20250135TT patent/HRP20250135T1/hr unknown
- 2020-09-23 CN CN202080080098.XA patent/CN114761084B/zh active Active
- 2020-09-23 WO PCT/US2020/052327 patent/WO2021061862A1/en not_active Ceased
- 2020-09-23 SM SM20250031T patent/SMT202500031T1/it unknown
- 2020-09-23 HU HUE20869739A patent/HUE069963T2/hu unknown
- 2020-09-23 ES ES20869739T patent/ES3008682T3/es active Active
- 2020-09-23 EP EP20869739.1A patent/EP4034252B1/en active Active
- 2020-09-23 RS RS20250107A patent/RS66476B1/sr unknown
- 2020-09-23 SI SI202030570T patent/SI4034252T1/sl unknown
- 2020-09-23 CN CN202311362358.4A patent/CN119569894A/zh active Pending
- 2020-09-23 FI FIEP20869739.1T patent/FI4034252T3/fi active
- 2020-09-23 IL IL307609A patent/IL307609B2/en unknown
- 2020-09-23 PL PL20869739.1T patent/PL4034252T3/pl unknown
- 2020-09-23 LT LTEPPCT/US2020/052327T patent/LT4034252T/lt unknown
- 2020-09-23 IL IL291558A patent/IL291558B2/en unknown
- 2020-09-23 BR BR112022005283A patent/BR112022005283A2/pt unknown
- 2020-09-23 KR KR1020227013693A patent/KR20220087454A/ko active Pending
- 2020-09-23 EP EP24200385.3A patent/EP4461748A3/en active Pending
- 2020-09-23 PT PT208697391T patent/PT4034252T/pt unknown
- 2020-09-23 DK DK20869739.1T patent/DK4034252T3/da active
- 2020-09-23 CA CA3155661A patent/CA3155661A1/en active Pending
-
2021
- 2021-03-30 US US17/217,618 patent/US11202801B2/en active Active
- 2021-11-17 US US17/529,091 patent/US11617766B2/en active Active
-
2023
- 2023-03-03 US US18/178,440 patent/US20240075062A1/en active Pending
-
2025
- 2025-10-10 JP JP2025171960A patent/JP2026047360A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022548796A5 (https=) | ||
| HRP20250135T1 (hr) | Notch receptori sa zglobnom domenom | |
| JP2025078629A5 (https=) | ||
| JP2022036976A5 (https=) | ||
| JP2021512635A5 (https=) | ||
| JP2024511423A5 (https=) | ||
| US20160000842A1 (en) | Oncolytic virus | |
| JP2021502104A5 (https=) | ||
| CN104592392B (zh) | 一种双特异性抗体EpCAM×CD3的构建及应用 | |
| CN113416258A (zh) | 一种多特异性抗体及其制备方法和用途 | |
| CN104829728A (zh) | 一种双特异性抗体her2xcd3的构建及应用 | |
| CN104592391A (zh) | 一种双特异性抗体EpCAM×CD3的构建及应用 | |
| JP2023519851A5 (https=) | ||
| CN104829727A (zh) | 一种双特异性抗体cd19×cd3的构建及应用 | |
| US20250000976A1 (en) | Anti-bcma single domain antibodies and therapeutic constructs | |
| TW201920272A (zh) | 一個需依賴標靶細胞使T細胞接合及活化之不對稱異二聚Fc-ScFv融合抗體形式及其在癌症治療上之應用 | |
| CN114437214B (zh) | 靶向lir1的抗体及其用途 | |
| JP2024512573A5 (https=) | ||
| WO2024037477A1 (zh) | 双特异性嵌合抗原受体和免疫细胞、制备方法、应用及肿瘤治疗药品 | |
| CN114853897B (zh) | 抗cd19/cd22/cd3三特异性抗体及用途 | |
| US20240158500A1 (en) | CD160 Binding Domain | |
| CN114075287B (zh) | 人源化bcma抗体和bcma-car-t细胞 | |
| CN114763387B (zh) | 一种基于结构优化蛋白活性的三特异性抗体制备方法 | |
| US20230399627A1 (en) | Vector genetically engineered with chimeric antigen receptor and against two or more targets and application thereof | |
| JP2023516945A5 (https=) |